Grant: Project Grant - Priority Announcement: Global Health Research
University of Calgary
$100,000.00
Defining the role of monocytes in protective immunity against healing and non-healing Leishmaniasis: implications for treatment and vaccination against phagosomal pathogens.
FY 2023-24
Summary
The objective of this grant is to gain a better understanding of the mechanisms of infected cell activation in settings of pre-existing T helper 1 (Th1)/Cell-mediated immunity (prior infection, vaccination) against phagosomal infections. Specifically the infection, manipulation, and activation of host monocytes following challenge infection with non-healing strains or clinical isolates of the protozoan parasite Leishmania. The new knowledge obtained by understanding these mechanisms should inform the downstream development of intervention strategies which, instead of targeting a specific pathogen (i.e. anti-microbials against specific bacteria, parasites or fungi), target a shared infectious process. These broad spectrum immuno-therapeutic approaches to treatment and prevention are likely to be successful against diverse pathogens and help alleviate the growing problem of antimicrobial resistance and long-term drug-treatment regimes.
Central Hypothesis: Non-healing strains and some clinical isolates of the Leishmania parasite evade pre-existing Th1 immunity via manipulation of TNF superfamily ligands on monocytes during a 'second stage' of parasite clearance.
AIM 1: In settings of pre-existing Th1 anti-Leishmania immunity (healed primary infections, vaccination), CD4 Th1 effector cell (Th1EFF)-mediated monocyte licensing and de novo activation of naïve recent thymic emigrants (RTEs) is required to facilitate a 'second stage' of parasite killing and complete control of challenge infection.
AIM 2: Certain clinical isolates, or species of Leishmania associated with non-healing infections, escape 'second stage' control via manipulation of infected CCR2+ monocytes and monocyte derived cells.
AIM 3: Evasion of 'second stage' control occurs via manipulation of TNF superfamily ligands on monocytes resulting in failed monocyte licencing and inefficient activation of recent thymic immigrants.
Department
Program
Project Grant - Priority Announcement: Global Health Research
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
495111
Name
Peters Nathan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Defining the role of monocytes in protective immunity against healing and non-healing Leishmaniasis: implications for treatment and vaccination against phagosomal pathogens.
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Global Health Research
Keyworddelim
Clinical Isolates; Intracellular Pathogens; Leishmania; Monocytes; Non-Healing Disease; Phagosomal Infections; T Cells; Tnfr Superfamily; Vaccination
Abstract
The objective of this grant is to gain a better understanding of the mechanisms of infected cell activation in settings of pre-existing T helper 1 (Th1)/Cell-mediated immunity (prior infection, vaccination) against phagosomal infections. Specifically the infection, manipulation, and activation of host monocytes following challenge infection with non-healing strains or clinical isolates of the protozoan parasite Leishmania. The new knowledge obtained by understanding these mechanisms should inform the downstream development of intervention strategies which, instead of targeting a specific pathogen (i.e. anti-microbials against specific bacteria, parasites or fungi), target a shared infectious process. These broad spectrum immuno-therapeutic approaches to treatment and prevention are likely to be successful against diverse pathogens and help alleviate the growing problem of antimicrobial resistance and long-term drug-treatment regimes.
Central Hypothesis: Non-healing strains and some clinical isolates of the Leishmania parasite evade pre-existing Th1 immunity via manipulation of TNF superfamily ligands on monocytes during a 'second stage' of parasite clearance.
AIM 1: In settings of pre-existing Th1 anti-Leishmania immunity (healed primary infections, vaccination), CD4 Th1 effector cell (Th1EFF)-mediated monocyte licensing and de novo activation of naïve recent thymic emigrants (RTEs) is required to facilitate a 'second stage' of parasite killing and complete control of challenge infection.
AIM 2: Certain clinical isolates, or species of Leishmania associated with non-healing infections, escape 'second stage' control via manipulation of infected CCR2+ monocytes and monocyte derived cells.
AIM 3: Evasion of 'second stage' control occurs via manipulation of TNF superfamily ligands on monocytes resulting in failed monocyte licencing and inefficient activation of recent thymic immigrants.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peters, Nathan
Approvedterm
1 an 0 mois
Cihrcontribution2
CRPPHE~ $100,000~ $0~